How to cross immunogenetic hurdles to human embryonic stem cell transplantation

Seminars in Immunopathology

Volumn 33, Issue 6, 2011, Pages 525-534

  De Rham, Casimir ^a   Villard, Jean ^a  

^a GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Embryonic stem transplantation; Immunosuppression; MHC; Minor antigen; Rejection

Indexed keywords

ALEMTUZUMAB; AZATHIOPRINE; BASILIXIMAB; CYCLOSPORIN A; EVEROLIMUS; GAMMA INTERFERON; HLA A ANTIGEN; HLA B ANTIGEN; HLA C ANTIGEN; HLA DP ANTIGEN; HLA DQ ANTIGEN; HLA DR ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MINOR HISTOCOMPATIBILITY ANTIGEN; MITOCHONDRIAL DNA; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN; STEROID; TACROLIMUS;

ALLOIMMUNITY; ALLOTRANSPLANTATION; ANTIBODY RESPONSE; ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN RECOGNITION; AUTOLOGOUS STEM CELL TRANSPLANTATION; BLOOD GROUP ABO INCOMPATIBILITY; BLOOD GROUP ABO SYSTEM; CD4+ T LYMPHOCYTE; CELL DIFFERENTIATION; CELL MATURATION; CHIMERA; DRUG MECHANISM; DRUG SAFETY; DRUG TOLERABILITY; EMBRYONIC STEM CELL; GASTROINTESTINAL DISEASE; GRAFT REJECTION; GRAFT VERSUS HOST REACTION; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; HYPERACUTE GRAFT REJECTION; IMMUNOGENETICS; IMMUNOGENICITY; IMMUNOLOGICAL MONITORING; IMMUNOLOGICAL TOLERANCE; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; NONHUMAN; OSTEOLYSIS; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; STEM CELL TRANSPLANTATION;

ANIMALS; BIOLOGICAL SPECIMEN BANKS; CHIMERISM; EMBRYONIC STEM CELLS; HUMANS; IMMUNOSUPPRESSION; MAJOR HISTOCOMPATIBILITY COMPLEX; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, AUTOLOGOUS; TRANSPLANTATION, HOMOLOGOUS;

EID: 81855175305     PISSN: 18632297     EISSN: 18632300     Source Type: Journal    
DOI: 10.1007/s00281-011-0262-z     Document Type: Review

References (52)

1. AJ Becker CE McCulloch JE Till 1963 Cytological demonstration of the clonal nature of spleen colonies derived from transplanted mouse marrow cells Nature 197 452 454 13970094 10.1038/197452a0 1:STN:280:DyaF387mtFyktA%3D%3D
2. LJ Kleinsmith GB Pierce Jr 1964 Multipotentiality of single embryonal carcinoma cells Cancer Res 24 1544 1551 14234000 1:STN:280: DyaF2M%2FjvVCitg%3D%3D
3. L Li ML Baroja A Majumdar K Chadwick A Rouleau L Gallacher, et al. 2004 Human embryonic stem cells possess immune-privileged properties Stem Cells 22 4 448 456 15277692 10.1634/stemcells.22-4-448 1:CAS:528:DC%2BD2cXps1Kns74%3D (Pubitemid 39014562)
4. PA Carpentier TD Palmer 2009 Immune influence on adult neural stem cell regulation and function Neuron 64 1 79 92 19840551 10.1016/j.neuron.2009.08.038 1:CAS:528:DC%2BD1MXhsFajsbbM
5. Z Abdullah T Saric H Kashkar N Baschuk B Yazdanpanah BK Fleischmann, et al. 2007 Serpin-6 expression protects embryonic stem cells from lysis by antigen-specific CTL J Immunol 178 6 3390 3399 17339433 1:CAS:528: DC%2BD2sXisVGjsr4%3D (Pubitemid 46417603)
6. DK Cooper 1990 Clinical survey of heart transplantation between ABO blood group-incompatible recipients and donors J Heart Transplant 9 4 376 381 2398432 1:STN:280:DyaK3czns1agug%3D%3D (Pubitemid 20279764)
7. J Molne P Bjorquist K Andersson M Diswall A Jeppsson V Strokan, et al. 2008 Blood group ABO antigen expression in human embryonic stem cells and in differentiated hepatocyte- and cardiomyocyte-like cells Transplantation 86 10 1407 1413 19034011 10.1097/TP.0b013e31818a6805
8. M Drukker G Katz A Urbach M Schuldiner G Markel J Itskovitz-Eldor, et al. 2002 Characterization of the expression of MHC proteins in human embryonic stem cells Proc Natl Acad Sci USA 99 15 9864 9869 12114532 10.1073/pnas.142298299 1:CAS:528:DC%2BD38XlslKgsLg%3D (Pubitemid 34831138)
9. G Desoye GA Dohr W Motter R Winter W Urdl H Pusch, et al. 1988 Lack of HLA class I and class II antigens on human preimplantation embryos J Immunol 140 12 4157 4159 3286768 1:STN:280:DyaL1c3ivFWhsA%3D%3D
10. JA Bradley EM Bolton RA Pedersen 2002 Stem cell medicine encounters the immune system Nat Rev Immunol 2 11 859 871 12415309 10.1038/nri934 1:CAS:528:DC%2BD38Xotlers7o%3D (Pubitemid 37328708)
11. AP Chidgey D Layton A Trounson RL Boyd 2008 Tolerance strategies for stem-cell-based therapies Nature 453 7193 330 337 18480814 10.1038/nature07041 1:CAS:528:DC%2BD1cXlvV2qtbc%3D (Pubitemid 351693139)
12. HG Ljunggren K Karre 1990 In search of the 'missing self': MHC molecules and NK cell recognition Immunol Today 11 7 237 244 2201309 10.1016/0167-5699(90) 90097-S 1:CAS:528:DyaK3cXls12rsbc%3D (Pubitemid 20198988)
13. M Drukker H Katchman G Katz S Even-Tov Friedman E Shezen E Hornstein 2006 Human embryonic stem cells and their differentiated derivatives are less susceptible to immune rejection than adult cells Stem Cells 24 2 221 229 16109762 10.1634/stemcells.2005-0188 (Pubitemid 44464789)
14. R Geeta RL Ramnath HS Rao V Chandra 2008 One year survival and significant reversal of motor deficits in parkinsonian rats transplanted with hESC derived dopaminergic neurons Biochem Biophys Res Commun 373 2 258 264 18565328 10.1016/j.bbrc.2008.06.022 1:CAS:528:DC%2BD1cXotlajsrg%3D
15. RJ Swijnenburg S Schrepfer JA Govaert F Cao K Ransohoff AY Sheikh, et al. 2008 Immunosuppressive therapy mitigates immunological rejection of human embryonic stem cell xenografts Proc Natl Acad Sci USA 105 35 12991 12996 18728188 10.1073/pnas.0805802105 1:CAS:528:DC%2BD1cXhtFSmtrnK
16. O Utermohlen M Kronke 2007 Survival of priceless cells: active and passive protection of embryonic stem cells against immune destruction Arch Biochem Biophys 462 2 273 277 17459325 10.1016/j.abb.2007.03.032 (Pubitemid 46856327)
17. JP Medema J de Jong LT Peltenburg EM Verdegaal A Gorter SA Bres, et al. 2001 Blockade of the granzyme B/perforin pathway through overexpression of the serine protease inhibitor PI-9/SPI-6 constitutes a mechanism for immune escape by tumors Proc Natl Acad Sci USA 98 20 11515 11520 11562487 10.1073/pnas. 201398198 1:CAS:528:DC%2BD3MXnt12jsr8%3D (Pubitemid 32928760)
18. O Utermohlen N Baschuk Z Abdullah A Engelmann U Siebolts C Wickenhauser, et al. 2009 Immunologic hurdles of therapeutic stem cell transplantation Biol Chem 390 10 977 983 19642871 10.1515/BC.2009.114
19. R Passier LW van Laake CL Mummery 2008 Stem-cell-based therapy and lessons from the heart Nature 453 7193 322 329 18480813 10.1038/nature07040 1:CAS:528:DC%2BD1cXlvV2qtbY%3D (Pubitemid 351693138)
20. PF Halloran 2004 Immunosuppressive drugs for kidney transplantation N Engl J Med 351 26 2715 2729 15616206 10.1056/NEJMra033540 1:CAS:528: DC%2BD2MXhtFWitw%3D%3D (Pubitemid 39665325)
21. GB Elion 1993 The George Hitchings and Gertrude Elion lecture. The pharmacology of azathioprine Ann NY Acad Sci 685 400 407 8363248 10.1111/j.1749-6632.1993.tb35897.x 1:STN:280:DyaK3szntVyrsA%3D%3D
22. O Adewumi B Aflatoonian L Ahrlund-Richter M Amit PW Andrews G Beighton, et al. 2007 Characterization of human embryonic stem cell lines by the International Stem Cell Initiative Nat Biotechnol 25 7 803 816 17572666 10.1038/nbt1318 1:CAS:528:DC%2BD2sXnsFaru7w%3D (Pubitemid 47052190)
23. O Preynat-Seauve C de Rham D Tirefort S Ferrari-Lacraz KH Krause J Villard 2009 Neural progenitors derived from human embryonic stem cells are targeted by allogeneic T and natural killer cells J Cell Mol Med 13 9B 3556 3569 19320778 10.1111/j.1582-4934.2009.00746.x
24. J Hunt A Cheng A Hoyles E Jervis CM Morshead 2010 Cyclosporin A has direct effects on adult neural precursor cells J Neurosci 30 8 2888 2896 20181586 10.1523/JNEUROSCI.5991-09.2010 1:CAS:528:DC%2BC3cXivVSnuro%3D
25. J Morales MR Bono A Fierro R Iniguez C Zehnder M Rosemblatt, et al. 2008 Alemtuzumab induction in kidney transplantation: clinical results and impact on T-regulatory cells Transplant Proc 40 9 3223 3228 19010240 10.1016/j. transproceed.2008.03.066 1:CAS:528:DC%2BD1cXhtlyksrrM
26. BD Kahan PR Rajagopalan M Hall United States Simulect Renal Study Group 1999 Reduction of the occurrence of acute cellular rejection among renal allograft recipients treated with basiliximab, a chimeric anti-interleukin-2- receptor monoclonal antibody Transplantation 67 2 276 284 10075594 10.1097/00007890-199901270-00016 1:CAS:528:DyaK1MXht1Cgu7g%3D (Pubitemid 29066355)
27. F Fandrich X Lin GX Chai M Schulze D Ganten M Bader, et al. 2002 Preimplantation-stage stem cells induce long-term allogeneic graft acceptance without supplementary host conditioning Nat Med 8 2 171 178 11821902 10.1038/nm0202-171 1:CAS:528:DC%2BD38Xht1equ7o%3D (Pubitemid 34155129)
28. A Uccelli L Moretta V Pistoia 2006 Immunoregulatory function of mesenchymal stem cells Eur J Immunol 36 10 2566 2573 17013987 10.1002/eji.200636416 1:CAS:528:DC%2BD28XhtFGqtrbI (Pubitemid 44608440)
29. M Sykes 2001 Mixed chimerism and transplant tolerance Immunity 14 4 417 424 11336687 10.1016/S1074-7613(01)00122-4 1:CAS:528:DC%2BD3MXjsVentrg%3D (Pubitemid 32441594)
30. Y Takahama 2006 Journey through the thymus: stromal guides for T-cell development and selection Nat Rev Immunol 6 2 127 135 16491137 10.1038/nri1781 1:CAS:528:DC%2BD28XhsFeqtbo%3D (Pubitemid 43361588)
31. T Kawai AB Cosimi TR Spitzer N Tolkoff-Rubin M Suthanthiran SL Saidman, et al. 2008 HLA-mismatched renal transplantation without maintenance immunosuppression N Engl J Med 358 4 353 361 18216355 10.1056/NEJMoa071074 1:CAS:528:DC%2BD1cXhtFCjsrg%3D (Pubitemid 351159234)
32. K Takahashi S Yamanaka 2006 Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors Cell 126 4 663 676 16904174 10.1016/j.cell.2006.07.024 1:CAS:528:DC%2BD28Xpt1aktbs%3D (Pubitemid 44233629)
33. K Takahashi K Tanabe M Ohnuki M Narita T Ichisaka K Tomoda, et al. 2007 Induction of pluripotent stem cells from adult human fibroblasts by defined factors Cell 131 5 861 872 18035408 10.1016/j.cell.2007.11.019 1:CAS:528:DC%2BD2sXhsVCntbbK (Pubitemid 350138099)
34. S Yamanaka 2009 A fresh look at iPS cells Cell 137 1 13 17 19345179 10.1016/j.cell.2009.03.034 1:CAS:528:DC%2BD1MXls1Sku7k%3D
35. S Yamanaka HM Blau 2010 Nuclear reprogramming to a pluripotent state by three approaches Nature 465 7299 704 712 20535199 10.1038/nature09229 1:CAS:528:DC%2BC3cXntF2mtbw%3D
36. JB Kim V Sebastiano G Wu MJ Arauzo-Bravo P Sasse L Gentile, et al. 2009 Oct4-induced pluripotency in adult neural stem cells Cell 136 3 411 419 19203577 10.1016/j.cell.2009.01.023 1:CAS:528:DC%2BD1MXltFSnsr4%3D
37. AD Ebert J Yu FF Rose Jr VB Mattis CL Lorson JA Thomson, et al. 2009 Induced pluripotent stem cells from a spinal muscular atrophy patient Nature 457 7227 277 280 19098894 10.1038/nature07677 1:CAS:528:DC%2BD1MXlvFWnsw%3D%3D
38. DW Fink Jr 2009 FDA regulation of stem cell-based products Science 324 5935 1662 1663 19556496 10.1126/science.1173712 1:CAS:528:DC%2BD1MXnsFOmsLs%3D
39. C Unger H Skottman P Blomberg MS Dilber O Hovatta 2008 Good manufacturing practice and clinical-grade human embryonic stem cell lines Hum Mol Genet 17 R1 R48 R53 18632697 10.1093/hmg/ddn079 1:CAS:528:DC%2BD1cXoslCmsro%3D
40. H Skottman MS Dilber O Hovatta 2006 The derivation of clinical-grade human embryonic stem cell lines FEBS Lett 580 12 2875 2878 16716780 10.1016/j.febslet.2006.03.083 1:CAS:528:DC%2BD28XltVKnt7s%3D (Pubitemid 43729174)
41. SC Lehec RD Hughes RR Mitry MA Graver A Verma JJ Wade, et al. 2009 Experience of microbiological screening of human hepatocytes for clinical transplantation Cell Transplant 18 8 941 947 19523347 10.3727/096368909X471323
42. JC Mountford 2008 Human embryonic stem cells: origins, characteristics and potential for regenerative therapy Transfus Med 18 1 1 12 18279188 10.1111/j.1365-3148.2007.00807.x 1:STN:280:DC%2BD1c7it1KmsA%3D%3D (Pubitemid 351239314)
43. G Lin Y Xie Q Ouyang X Qian P Xie X Zhou, et al. 2009 HLA-matching potential of an established human embryonic stem cell bank in China Cell Stem Cell 5 5 461 465 19896436 10.1016/j.stem.2009.10.009 1:CAS:528: DC%2BD1MXhsFKltLvN
44. N Nakatsuji F Nakajima K Tokunaga 2008 HLA-haplotype banking and iPS cells Nat Biotechnol 26 7 739 740 18612291 10.1038/nbt0708-739 1:CAS:528:DC%2BD1cXot1entr8%3D (Pubitemid 351961440)
45. CJ Taylor EM Bolton S Pocock LD Sharples RA Pedersen JA Bradley 2005 Banking on human embryonic stem cells: estimating the number of donor cell lines needed for HLA matching Lancet 366 9502 2019 2025 16338451 10.1016/S0140- 6736(05)67813-0 (Pubitemid 41773377)
46. JE Lee MS Kang MH Park SH Shim TK Yoon HM Chung, et al. 2010 Evaluation of 28 human embryonic stem cell lines for use as unrelated donors in stem cell therapy: implications of HLA and ABO genotypes Cell Transplant 19 11 1383 1395 20587141 10.3727/096368910X513991
47. MK Carpenter MS Inokuma J Denham T Mujtaba CP Chiu MS Rao 2001 Enrichment of neurons and neural precursors from human embryonic stem cells Exp Neurol 172 2 383 397 11716562 10.1006/exnr.2001.7832 1:CAS:528:DC%2BD3MXosFGht78%3D (Pubitemid 34075087)
48. C Xu S Police N Rao MK Carpenter 2002 Characterization and enrichment of cardiomyocytes derived from human embryonic stem cells Circ Res 91 6 501 508 12242268 10.1161/01.RES.0000035254.80718.91 1:CAS:528:DC%2BD38XotFehurw%3D
49. L Rambhatla CP Chiu P Kundu Y Peng MK Carpenter 2003 Generation of hepatocyte-like cells from human embryonic stem cells Cell Transplant 12 1 1 11 12693659 10.3727/000000003783985179 (Pubitemid 36397310)
50. LP Frenzel Z Abdullah AK Kriegeskorte R Dieterich N Lange DH Busch, et al. 2009 Role of natural-killer group 2 member D ligands and intercellular adhesion molecule 1 in natural killer cell-mediated lysis of murine embryonic stem cells and embryonic stem cell-derived cardiomyocytes Stem Cells 27 2 307 316 18988711 10.1634/stemcells.2008-0528 1:CAS:528:DC%2BD1MXjslSjsbs%3D
51. LG Guidotti K Ando MV Hobbs T Ishikawa L Runkel RD Schreiber, et al. 1994 Cytotoxic T lymphocytes inhibit hepatitis B virus gene expression by a noncytolytic mechanism in transgenic mice Proc Natl Acad Sci USA 91 9 3764 3768 8170985 10.1073/pnas.91.9.3764 1:CAS:528:DyaK2cXivFKmtLk%3D (Pubitemid 24139512)
52. LG Guidotti T Ishikawa MV Hobbs B Matzke R Schreiber FV Chisari 1996 Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes Immunity 4 1 25 36 8574849 10.1016/S1074-7613(00)80295-2 1:CAS:528: DyaK28Xos1Kltw%3D%3D (Pubitemid 26054933)